MYDA Advisors’s Core Scientific CORZ Stock Holding History

MYDA Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.9M	Sell	700,000 -460,000	-40%	-$10.8M	2.67%	7
2026 Q1	$17.4M	Sell	1,160,000 -7,000	-0.6%	-$119K	2.85%	5
2025 Q4	$17M	Buy	1,167,000 +47,000	+4%	+$820K	3.24%	7
2025 Q3	$20.1M	Sell	1,120,000 -601,000	-35%	-$8.81M	4.34%	3
2025 Q2	$29.4M	Sell	1,721,000 -329,294	-16%	-$3.3M	5.13%	3
2025 Q1	$14.8M	Buy	2,050,294 +687,793	+50%	+$7.83M	2.58%	9
2024 Q4	$19.1M	Buy	1,362,501 +72,501	+6%	+$1.07M	4.82%	1
2024 Q3	$15.3M	Buy	1,290,000 +545,000	+73%	+$5.65M	3.36%	6
2024 Q2	$6.93M	Buy	745,000 +155,000	+26%	+$792K	1.5%	24
2024 Q1	$2.09M	Buy	+590,000	New	+$2.05M	0.6%	49

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

MYDA Advisors's CORZ Position: Q2 2026 in Review

MYDA Advisors reduced its Core Scientific (CORZ) stake by 40% in Q2 2026, selling an estimated $10.8M and leaving 700,000 shares worth $17.9M. The position accounts for 2.67% of the portfolio, ranked #7.

MYDA Advisors first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $29.4M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

MYDA Advisors held 700,000 shares of Core Scientific worth $17.9M as of Q2 2026.
MYDA Advisors sold 460,000 Core Scientific shares in Q2 2026, an estimated $10.8M.
Core Scientific made up 2.67% of MYDA Advisors's portfolio in Q2 2026, its #7 holding.
MYDA Advisors first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
MYDA Advisors's Core Scientific position peaked at $29.4M in Q2 2025.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on MYDA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.